NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Citeline announces the launch of
Global Patient Insights, the industry's most comprehensive view of the worldwide
patient landscape, designed to optimize the site selection process for clinical
trial sponsors.
Global Patient Insights seamlessly integrates real-world data on patient
population and diversity with Sitetrove's best-in-class site and investigator
intelligence. This robust RWD dataset includes global electronic health records,
census and epidemiology data, along with U.S. social determinants of health
(SDOH) and medical claims data?.
The race to develop a COVID-19 vaccine underscored the importance of diversity
in clinical trials. Despite efforts to improve trial diversity by regulatory
agencies, including the U.S. Food and Drug Administration and the European
Medicines Agency, clinical trials still lack representation among key racial and
ethnic minority groups.
With Global Patient Insights, study sponsors will be able to easily locate sites
with clinically relevant and diverse patient populations by:

  * Prioritizing countries and global sites with higher volumes of
    clinically relevant patient populations
  * Identifying U.S. physicians near investigators with access to the right
    patients for referrals?
  * Visualizing patient populations via dynamic dashboards and heatmaps

"Global Patient Insights takes Sitetrove to an exciting new level," says
Christina Masturzo, Citeline Vice President, Product Management. "For sponsors,
it's the best of both worlds: our gold-standard Sitetrove data, coupled with
information-rich real-world data. In fact, our product team refers to it as
'Sitetrove on steroids.'
"Our goal at Citeline is to get the right treatments to the right patients at
the right time. We do this by guiding sponsors throughout the drug development
life cycle, from study design and protocol development through to site
selection, patient recruitment and, ultimately, enrollment."
Learn more about Citeline's Global Patient Insights at Citeline.com.
About Citeline
Citeline, a Norstella (https://www.norstella.com/) company, powers a full suite
of complementary business intelligence offerings to meet the evolving needs of
life science professionals to accelerate the connection of treatments to
patients and patients to treatments. These patient-focused solutions and
services deliver and analyze data used to drive clinical, commercial, and
regulatory-related decisions and create real-world opportunities for growth.
Citeline's global teams of analysts, journalists, and consultants keep their
fingers on the pulse of the pharmaceutical, biomedical and medtech industries,
covering them with expert insights: key diseases, clinical trials, drug R&D and
approvals, market forecasts, and more. For more information on one of the
world's most trusted health science partners, visit Citeline
(http://www.citeline.com) and follow on LinkedIn
(https://www.linkedin.com/company/citeline/) and X
(https://twitter.com/Citeline).
Citeline PR contact:
Diffusion PR for Citeline
citeline@diffusionpr.com (mailto:citeline@diffusionpr.com)
(213) 318-4500
Â